Because no changes were observed in circulating IL-18 levels between CKD patients with and without AF or between WT-sham and WT-CKD mice, IL-1β is probably the main trigger of NLPR3 activation in the atria in CKD. The gene discussed is IL18; the disease is atrial fibrillation.